Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population

Disease Markers

Volumn 35, Issue 6, 2013, Pages 799-805

  Tang, Shengli ^a   Liu, Zhisu ^a   Zhang, Yongxi ^a   He, Yueming ^a   Pan, Dingyu ^a   Liu, Yuanyuan ^b   Liu, Quanyan ^a   Zhang, Zhonglin ^a   Yuan, Yufeng ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HUMAN; IL 6 GENE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84896970631     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/508023     Document Type: Article

References (41)

1. Lee W. M., Hepatitis B virus infection. The New England Journal of Medicine 1997 337 24 1733 1745 2-s2.0-0030707941 10.1056/NEJM199712113372406
2. Lok A. S. F., McMahon B. J., Chronic hepatitis B. Hepatology 2001 34 6 1225 1241 2-s2.0-0035189597 10.1053/jhep.2001.29401
3. Alter M. J., Epidemiology and prevention of hepatitis B. Seminars in Liver Disease 2003 23 1 39 46 2-s2.0-0037330951
4. Cacciola I., Cerenzia G., Pollicino T., Squadrito G., Castellaneta S., Zanetti A. R., Mieli-Vergani G., Raimondo G., Genomic heterogeneity of Hepatitis B Virus (HBV) and outcome of perinatal HBV infection. Journal of Hepatology 2002 36 3 426 432 2-s2.0-0036186423 10.1016/S0168-8278(01)00295-1
5. Lin T. M., Chen C. J., Wu M. M., Yang C. S., Chen J. S., Lin C. C., Kwang T. Y., Hsu S. T., Lin S. Y., Hsu L. C., Hepatitis B virus marker in Chinese twins. Anticancer Research 1989 9 3 737 741 2-s2.0-0024325653
6. Thursz M., Genetic susceptibility in chronic viral hepatitis. Antiviral Research 2001 52 2 113 116 2-s2.0-0034769202 10.1016/S0166-3542(01)00175-9
7. Migita K., Maeda Y., Abiru S., Nakamura M., Komori A., Miyazoe S., Nakao K., Yatsuhashi H., Eguchi K., Ishibashi H., Polymorphisms of interleukin-1 β in Japanese patients with hepatitis B virus infection. Journal of Hepatology 2007 46 3 381 386 2-s2.0-33846610504 10.1016/j.jhep.2006.09.015
8. Deng G., Zhou G., Zhang R., Zhai Y., Zhao W., Yan Z., Deng C., Yuan X., Xu B., Dong X., Zhang X., Zhang X., Yao Z., Shen Y., Qiang B., Wang Y., He F., Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers. Gastroenterology 2008 134 3 716.e2 726.e2 2-s2.0-39749102982 10.1053/j.gastro.2007.12.044
9. Ayada M., Ishikawa T., Okumura A., Tanabe J., Ito H., Ohashi T., Matsumoto E., Sato K., Hotta N., Fukuzawa Y., Kakumu S., Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection. Hepatology Research 2006 34 4 214 221 2-s2.0-33645027908 10.1016/j.hepres.2006. 01.001
10. Du W. J., Zhen J. H., Zeng Z. Q., Expression of Interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagnostic Pathology 2013 8, article 40 10.1186/1746-1596-8-40
11. Giannitrapani L., Cervello M., Soresi M., Notarbartolo M., La Rosa M., Virruso L., D'Alessandro N., Montalto G., Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma. Annals of the New York Academy of Sciences 2002 963 46 52 2-s2.0-0036291101
12. Song L. H., Binh V. Q., Duy D. N., Kun J. F. J., Bock T. C., Kremsner P. G., Luty A. J. F., Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. Journal of Clinical Virology 2003 28 1 93 103 2-s2.0-0041589356 10.1016/S1386-6532(02)00271-8
13. Porta C., de Amici M., Quaglini S., Paglino C., Tagliani F., Boncimino A., Moratti R., Corazza G. R., Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Annals of Oncology 2008 19 2 353 358 2-s2.0-38849106118 10.1093/annonc/mdm448
14. Naugler W. E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A. M., Karin M., Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007 317 5834 121 124 2-s2.0-34447327216 10.1126/science.1140485
15. Naugler W. E., Karin M., The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in Molecular Medicine 2008 14 3 109 119 2-s2.0-40649109728 10.1016/j.molmed.2007.12.007
16. Fishman D., Faulds G., Jeffey R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 1998 102 7 1369 1376 2-s2.0-0032189103
17. Bao S., Yang W., Zhou S., Ye Z., Relationship between single nucleotide polymorphisms in -174G/C and -634C/G promoter region of interleukin-6 and prostate cancer. Journal of Huazhong University of Science and Technology 2008 28 6 693 696 2-s2.0-58149109271 10.1007/s11596-008-0618-3
18. Gangwar R., Mittal B., Mittal R. D., Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer. International Journal of Biological Markers 2009 24 1 11 16 2-s2.0-67649989519
19. Tong Y., Wang Z., Geng Y., Liu J., Zhang R., Lin Q., Li X., Huang D., Gao S., Hu D., Li Y., Cheng J., Lu Z., The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochemical and Biophysical Research Communications 2010 391 1 481 485 2-s2.0-72949091661 10.1016/j.bbrc.2009.11.084
20. Yu Y., Wang W., Zhai S., Dang S., Sun M., IL6 gene polymorphisms and susceptibility to colorectal cancer: a meta-analysis and review. Molecular Biology Reports 2012 39 8 8457 8463 10.1007/s11033-012-1699-4
21. Zhai R., Liu G., Yang C., Huang C., Wu C., Christiani D. C., The G to C polymorphism at -174 of the interleukin-6 gene is rare in a southern Chinese population. Pharmacogenetics 2001 11 8 699 701 2-s2.0-0035166190 10.1097/00008571-200111000-00008
22. Park B. L., Lee H.-S., Kim Y. J., Kim J. Y., Jung J. H., Kim L. H., Shin H. D., Association between interleukin 6 promoter variants and chronic hepatitis B progression. Experimental and Molecular Medicine 2003 35 2 76 82 2-s2.0-0038147057
23. Bruix J., Sherman M., Management of hepatocellular carcinoma. Hepatology 2005 42 5 1208 1236 2-s2.0-28844480321 10.1002/hep.20933
24. Hui C.-K., Lau G. K. K., Immune system and hepatitis B virus infection. Journal of Clinical Virology 2005 34 1 S44 S48 2-s2.0-32044466281 10.1016/S1386-6532(05)80009-5
25. Huang C.-F., Lin S.-S., Ho Y.-C., Chen F.-L., Yang C.-C., The immune response induced by hepatitis B virus principal antigens. Cellular & Molecular Immunology 2006 3 2 97 106 2-s2.0-33745727513
26. Cressman D. E., Greenbaum L. E., DeAngelis R. A., Ciliberto G., Furth E. E., Poli V., Taub R., Liver failure and defective hepatocyte regeneration in interleukin-6- deficient mice. Science 1996 274 5291 1379 1383 2-s2.0-0029846756 10.1126/science.274.5291.1379
27. Hsia C.-Y., Huo T.-I., Chiang S.-Y., Lu M.-F., Sun C.-L., Wu J.-C., Lee P.-C., Chi C.-W., Lui W.-Y., Lee S.-D., Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. European Journal of Surgical Oncology 2007 33 2 208 212 2-s2.0-33847344307 10.1016/j.ejso.2006.10.036
28. Zhang X., Hong X., Deng G., Bai X., Single nucleotide polymorphisms and functional analysis of class II transactivator (CIITA) promoter IV in persistent HBV infection. Journal of Clinical Virology 2007 40 3 197 201 2-s2.0-35148879225 10.1016/j.jcv.2007.08.016
29. An P., Winkler C., Guan L., O'Brien S. J., Zeng Z., Yu Y., Xu X., Lu H., Hu D., Wang R., Chen Y., Hao C., Zhou H., Han Z., Wang Y., Sun X., Bao L., Zhang X., Guo D., Zhang Y., Dou X., Wei L., Rui J., Qu Q., A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. Journal of Infectious Diseases 2011 203 7 943 947 2-s2.0-79953015941 10.1093/infdis/jiq154
30. Wu J. F., Chen C. H., Ni Y. H., Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan. Journal of Infectious Diseases 2012 206 5 662 668 10.1093/infdis/jis420
31. Chong W. P., To Y. F., Ip W. K., Yuen M. F., Poon T. P., Wong W. H. S., Lai C. L., Lau Y. L., Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology 2005 42 5 1037 1045 2-s2.0-30044438804 10.1002/hep.20891
32. Berasain C., Castillo J., Perugorria M. J., Latasa M. U., Prieto J., Avila M. A., Inflammation and liver cancer: new molecular links. Annals of the New York Academy of Sciences 2009 1155 206 221 2-s2.0-61649106928 10.1111/j.1749-6632.2009.03704.x
33. Kakumu S., Shinagawa T., Ishikawa T., Yoshioka K., Wakita T., Ito Y., Takayanagi M., Ida N., Serum interleukin 6 levels in patients with chronic hepatitis B. American Journal of Gastroenterology 1991 86 12 1804 1808 2-s2.0-0025786730
34. Khoruts A., Stahnke L., McClain C. J., Logan G., Allen J. I., Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991 13 2 267 276 2-s2.0-0026026639 10.1016/0270-9139(91)92439-F
35. Nakagawa H., Maeda S., Yoshida H., Tateishi R., Masuzaki R., Ohki T., Hayakawa Y., Kinoshita H., Yamakado M., Kato N., Shiina S., Omata M., Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. International Journal of Cancer 2009 125 10 2264 2269 2-s2.0-70349849505 10.1002/ijc.24720
36. Maurizio S., Lydia G., Fabio D., Maria F. A., Emanuele L. S., Angela T., Melchiorre C., Natale D., Giuseppe M., Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World Journal of Gastroenterology 2006 12 16 2563 2568 2-s2.0-33646458250
37. Napoli J., Bishop G. A., McCaughan G. W., Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology 1994 107 3 789 798 2-s2.0-0028129336
38. Toda K., Kumagai N., Tsuchimoto K., Inagaki H., Suzuki T., Oishi T., Atsukawa K., Saito H., Morizane T., Hibi T., Ishii H., Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. Journal of Gastroenterology 2000 35 3 214 220 2-s2.0-0034034594
39. Lee Y., Park U.-S., Choi I., Yoon S. K., Park Y. M., Lee Y. I., Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clinical Cancer Research 1998 4 7 1711 1717 2-s2.0-0031746396
40. Reichner J. S., Mulligan J. A., Spisni R., Sotomayor E. A., Albina J. E., Bland K. I., Effect of IL-6 overexpression on the metastatic potential of rat hepatocellular carcinoma cells. Annals of Surgical Oncology 1998 5 3 279 286 2-s2.0-0031811737 10.1007/BF02303786
41. Kovalovich K., Li W., DeAngelis R., Greenbaum L. E., Ciliberto G., Taub R., Interleukin-6 protects against Fas-mediated feath by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. Journal of Biological Chemistry 2001 276 28 26605 26613 2-s2.0-0035854780 10.1074/jbc.M100740200